Related Experiment Video

Updated: May 7, 2026

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

From bench to bedside: does preclinical practice in translational oncology need some rebuilding?

Andrea Bertotti1, Livio Trusolino

  • 1Affiliations of authors: Department of Oncology, University of Torino Medical School (AB, LT); Laboratory of Molecular Pharmacology, Institute for Cancer Research and Treatment (AB, LT), Candiolo, Torino, Italy.

Journal of the National Cancer Institute
|September 21, 2013
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Working with Human Tissues for Translational Cancer Research
07:48

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

Related Experiment Videos

Last Updated: May 7, 2026

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Working with Human Tissues for Translational Cancer Research
07:48

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

Articles linked to this work by shared authors, journal, and citation graph.

Inference of lineage hierarchies, growth, and drug response mechanisms in cancer cell populations without tracking.

Cell reports methods·2026

Efficacy of dual KRASG12D-EGFR blockade versus triple combinations in patient-derived models of KRASG12D-mutant colorectal cancer.

Cell death & disease·2026

WEE1 kinase inhibition to overcome acquired resistance to targeted therapies in colorectal cancer.

EMBO molecular medicine·2026

Omega-3 fatty acid DHA induces ferroptosis in colorectal cancer patient-derived organoids and drug-tolerant cells.

Cell death & disease·2026

Unraveling lung cancer dynamics: a new metabolic signature improving the prediction of recurrence in resected lung adenocarcinoma.

Journal of translational medicine·2026

Interrogating the immune landscape of microsatellite stable RAS-mutated colon cancer.

Molecular oncology·2026

Addressing the impact of tobacco and alcohol use on cancer-related health outcomes.

Journal of the National Cancer Institute·2026

Epigenetic aging of colorectal mucosa in cancer development.

Journal of the National Cancer Institute·2026

Randomized trial of adjuvant 5-FU-platinum vs paclitaxel-platinum for high-risk penile cancer.

Journal of the National Cancer Institute·2026

Concurrent chemotherapy and external radiation therapy (ConCERT): phase 3 noninferiority randomized clinical trial of cisplatin weekly vs every 3 weeks in locally advanced squamous cell carcinoma of the head and neck.

Journal of the National Cancer Institute·2026

Evaluating longitudinal toxicity and adverse event in cetuximab-treated metastatic colorectal cancer: a pooled analysis from 1,302 patients in ARCAD database.

Journal of the National Cancer Institute·2026

Pharmacogenetic variants in the molecular characterization initiative: a report from the children's oncology group.

Journal of the National Cancer Institute·2026

Radiomodulatory effects of rosmarinic acid in melanocytic cells.

International journal of radiation biology·2026

Real-World Treatment Trajectories Following Near-Infrared Photoimmunotherapy in Head and Neck Cancer: Implications for Clinical Decision-Making.

Head & neck·2026

Novel lateral fiducial marker positioning technique eliminates registration failures in high-body mass index patients during robot-assisted spine surgery.

Journal of craniovertebral junction & spine·2026

Experimental Validation and Calibration of Cherenkov Imaging for Real-Time Surface Dosimetry in Photon Breast Therapy.

Proceedings of SPIE--the International Society for Optical Engineering·2026

Association of Combined Iodine-125 Seed Implantation and Atezolizumab/Bevacizumab with Improved Outcomes in Recurrent Hepatocellular Carcinoma After Hepatectomy: A Comparative Retrospective Analysis.

Journal of hepatocellular carcinoma·2026

Case Report: Dose-escalated volumetric modulated arc therapy achieving bowel and renal protection for large retroperitoneal inflammatory myofibroblastic tumor invading ureter and inferior vena cava.

Frontiers in oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us